Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients ...
In the short term, Eli Lilly and Novo Nordisk will continue to dominate due to strong branding and doctor trust. But in the ...
More work needs to be done to tease out the mechanisms by which GLP-1 RAs lower the risk of MACE, researchers say.
DOCTORS have dubbed her the “Ozempic poster girl” after she managed to keep her six stone weight loss off for two YEARS after ...
Ortho Molecular Products, a leading nutraceutical manufacturer exclusively serving licensed health care practitioners, has partnered with New Zealand–based Calocurb® to bring Calocurb® CLINICAL to the ...
Weight loss medications can be lifesaving for people who need them — but there are errors you’ll want to avoid.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR ...
MedPage Today on MSN
Real-World Data Back GLP-1s in Asthma, Cardiopulmonary Conditions
CHICAGO -- A series of large, real-world analyses supported benefit of GLP-1 receptor agonists in cardiopulmonary indications for patients with type 2 diabetes, researchers reported at the CHEST ...
Development of the latest class of incretin-based therapeutics for diabetes and obesity has been heralded as a major step ...
Researchers at Virginia Polytechnic Institute and State University took 20 people living with obesity (half on GLP-1s like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback